MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer

Journal Article

Full Text

Duke Authors

Cited Authors

  • Hew, KE; Miller, PC; El-Ashry, D; Sun, J; Besser, AH; Ince, TA; Gu, M; Wei, Z; Zhang, G; Brafford, P; Gao, W; Lu, Y; Mills, GB; Slingerland, JM; Simpkins, F

Published Date

  • February 15, 2016

Published In

Volume / Issue

  • 22 / 4

Start / End Page

  • 935 - 947

Published By

Electronic International Standard Serial Number (EISSN)

  • 1557-3265

International Standard Serial Number (ISSN)

  • 1078-0432

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.ccr-15-0534


  • en